EQL Pharma AB (publ) (FRA:7JK)
Germany · Delayed Price · Currency is EUR 4.900
-0.005 (-0.10%)
At close: Nov 28, 2025
EQL Pharma AB Cash Flow Statement
Financials in millions SEK. Fiscal year is April - March.
Millions SEK. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
Net Income | 29.61 | 43.12 | 22.71 | 30.92 | 31.55 | 10.37 | Upgrade |
Depreciation & Amortization | 10.1 | 10.1 | 7.66 | 7.43 | 2.76 | - | Upgrade |
Other Amortization | 2.42 | 2.42 | 0.62 | 1.14 | 0.78 | - | Upgrade |
Asset Writedown & Restructuring Costs | - | - | 0.47 | 7.84 | 6.73 | - | Upgrade |
Other Operating Activities | 14.42 | 11.23 | 0.07 | 8.13 | 7.2 | 18.41 | Upgrade |
Change in Accounts Receivable | -36.88 | -67.15 | -14.25 | -16.86 | -11.69 | -6.27 | Upgrade |
Change in Inventory | -58.87 | -73.41 | -40.26 | -23.69 | 0.68 | -14 | Upgrade |
Change in Other Net Operating Assets | 31.02 | 49.04 | 11.54 | 12.72 | 3.83 | 51.54 | Upgrade |
Operating Cash Flow | -8.18 | -24.65 | -11.44 | 27.62 | 41.83 | 60.05 | Upgrade |
Operating Cash Flow Growth | - | - | - | -33.98% | -30.34% | 797.97% | Upgrade |
Capital Expenditures | -11.01 | -6.13 | -0.93 | -0.46 | -0.63 | -0.41 | Upgrade |
Sale (Purchase) of Intangibles | -254.36 | -239.72 | -65.34 | -20.05 | -21.46 | -55.17 | Upgrade |
Other Investing Activities | - | -0 | - | -0 | - | - | Upgrade |
Investing Cash Flow | -265.37 | -245.84 | -66.26 | -20.51 | -22.09 | -55.58 | Upgrade |
Long-Term Debt Issued | - | 357.94 | 53.97 | - | 0.6 | 12.88 | Upgrade |
Long-Term Debt Repaid | - | -25.71 | -0.49 | -4.07 | -6.58 | -1.08 | Upgrade |
Net Debt Issued (Repaid) | 307.49 | 332.23 | 53.48 | -4.07 | -5.98 | 11.8 | Upgrade |
Issuance of Common Stock | 32.49 | 0.19 | 0.27 | 0.19 | 0.86 | - | Upgrade |
Other Financing Activities | - | - | - | 0 | - | - | Upgrade |
Financing Cash Flow | 339.98 | 332.43 | 53.74 | -3.88 | -5.12 | 11.8 | Upgrade |
Miscellaneous Cash Flow Adjustments | - | - | -0 | - | - | - | Upgrade |
Net Cash Flow | 66.43 | 61.93 | -23.96 | 3.23 | 14.62 | 16.27 | Upgrade |
Free Cash Flow | -19.19 | -30.78 | -12.36 | 27.16 | 41.2 | 59.64 | Upgrade |
Free Cash Flow Growth | - | - | - | -34.08% | -30.92% | 864.27% | Upgrade |
Free Cash Flow Margin | -4.81% | -8.24% | -4.68% | 10.45% | 10.05% | 33.29% | Upgrade |
Free Cash Flow Per Share | -0.63 | -1.03 | -0.41 | 0.92 | 1.42 | 2.05 | Upgrade |
Cash Interest Paid | 24.52 | 13.02 | 4.01 | 2.29 | 2.78 | - | Upgrade |
Cash Income Tax Paid | - | - | - | - | - | 0.06 | Upgrade |
Levered Free Cash Flow | -290.39 | -291.16 | -89.53 | -9.9 | 1.84 | -60.68 | Upgrade |
Unlevered Free Cash Flow | -275.48 | -283.45 | -85.95 | -8.42 | 3.64 | -59.99 | Upgrade |
Change in Working Capital | -64.74 | -91.52 | -42.96 | -27.83 | -7.18 | 31.27 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.